Goldilocks and the BCG: Bacillus Calmette-Guérin Dose Reduction in the Age of Shortage

Affiliations

¹ Department of Urology, University of North Carolina, Chapel Hill, NC, USA.
² Department of Urology, University of North Carolina, Chapel Hill, NC, USA; Lineberger Comprehensive Cancer Center, Multidisciplinary Genitourinary Oncology, Chapel Hill, NC, USA. Electronic address: angela_smith@med.unc.edu.

Editorial

Christine V Nikas et al. Eur Urol. 2020 Nov.

. 2020 Nov;78(5):699-700.

doi: 10.1016/j.eururo.2020.05.021. Epub 2020 Jun 9.

¹ Department of Urology, University of North Carolina, Chapel Hill, NC, USA.
² Department of Urology, University of North Carolina, Chapel Hill, NC, USA; Lineberger Comprehensive Cancer Center, Multidisciplinary Genitourinary Oncology, Chapel Hill, NC, USA. Electronic address: angela_smith@med.unc.edu.

No abstract available

Comment on

Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS".
Grimm MO, van der Heijden AG, Colombel M, Muilwijk T, Martínez-Piñeiro L, Babjuk MM, Türkeri LN, Palou J, Patel A, Bjartell AS, Caris C, Schipper RG, Witjes WPJ; EAU Research Foundation NIMBUS Study Group. Grimm MO, et al. Eur Urol. 2020 Nov;78(5):690-698. doi: 10.1016/j.eururo.2020.04.066. Epub 2020 May 20. Eur Urol. 2020. PMID: 32446864 Clinical Trial.

1. Plesca M., Bordea C., El Houcheimi B., Ichim E., Blidaru A. Evolution of radical mastectomy for breast cancer. J Med Life. 2016;9:183–186. - PMC - PubMed
1. Doolittle J., Piotrowski J., Zuk K. Evolving trends for selected treatments of T1a renal cell carcinoma. Urology. 2019;132:136–142. - PubMed
1. Dall’Era M.A., Albertsen P.C., Bangma C. Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol. 2012;62:976–983. - PubMed
1. Ourfali S, Ohannessian R, Fassi-Fehri H, Pages A, Bade L, Colombel M. Recurrence rate and cost consequence of the shortage of bacillus Calmette-Guérin Connaught strain for bladder cancer patients. Eur Urol Focus. In press. 10.1016/j.euf.2019.04.002. - DOI - PubMed
1. Morales A., Eidinger D., Bruce A.W. Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol. 1976;116:180–183. - PubMed